Scientific Review Board P - S

A - E F - J K - O P - S T - Z
Giulio Pasinetti, MD, PhD
Mount Sinai School of Medicine
New York, NY
George Perry, PhD
University of Texas at San Antonio
San Antonio, TX
Ronald C. Petersen, MD, PhD
Mayo Clinic College of Medicine
Rochester, MN

Michael Polydefkis, MD
Johns Hopkins Univ/School of Medicine
Baltimore, MD
William Potter, MD, PhD
Lilly Research Laboratories
Indianapolis, IN
Donald L. Price, MD
ohns Hopkins University
Baltimore, MD
Ram Ramabhadran, PhD
Environmental Protection Agency
Research Triangle Park, NC
G. William Rebeck, PhD
Georgetown University
School of Medicine
Washington, DC
George W. Rebok, PhD
Johns Hopkins University
Baltimore, MD
Eric Reiman, MD
Banner Good Samaritan Medical Center
Phoenix, AZ
Nikolaos K. Robakis, PhD
Mount Sinai School of Medicine
Bronx, NY
Jack Rogers, PhD
Massachusetts General Hospital
Charlestown, MA
Barbara Sahagan, PhD
Pfizer, Inc.
Groton, CT
Stephen Salloway, MD
Butler Hospital
Providence, RI
Kumar Sambamurti, PhD
Medical University of S Carolina
Charleston, SC
Philip Scheltens, PhD
VU University Medical Center
Amsterdam, The Netherlands
Dale Schenk, PhD
Elan Pharmaceuticals
South San Francisco, CA
Alexander Scriabine, MD
Guilford, CT

Diana Shineman
Institute for the Study of Aging
New York, NY
Einar M. Sigurdsson, PhD
NYU School of Medicine
New York, NY
Israel Silman, PhD
The Weizmann Institute of Science
Rehovot, Israel

Ely Simon, MD
NeuroTrax Corporation
Bayside, NY
Gary W. Small, MD UCLA
Neuropsychiatric Institute
Los Angeles, CA
Scott A. Small, MD
Columbia University
New York, NY
Reisa Sperling, MD
Harvard Medical School
Belmont, MA
Ross L. Stein, PhD
Brigham and Women’s Hospital
Boston, MA
Yaakov Stern, PhD
Columbia University
New York, NY
Joel L. Sussman, PhD
The Weizmann Institute of Science
Rehovot, Israel

1 out of 3 individuals will be affected by Alzheimer's Disease by the age of 80.

Donate Now

We're doing whatever it takes to find a cure for Alzheimer's Disease. But we can't do it without you. Please give generously today. Learn More

Apply for a Grant

ADDF invites scientists to apply for a grant through its Novel Approaches to Drug Discovery for Alzheimer's Disease research award program. Learn More